LETROZOLE DEXCEL

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

LETROZOLE

Dostupné s:

DEXCEL LTD, ISRAEL

ATC kód:

L02BG04

Léková forma:

FILM COATED TABLETS

Složení:

LETROZOLE 2.5 MG

Podání:

PER OS

Druh předpisu:

Required

Výrobce:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Terapeutické skupiny:

LETROZOLE

Terapeutické oblasti:

LETROZOLE

Terapeutické indikace:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Datum autorizace:

2016-02-29